SBSaeede Khosravi Bizhaem

Saeede Khosravi Bizhaem

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Saeede Khosravi Bizhaem has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Heart Status Regarding Opium and Psychotropics Use in Corpses Referred to Birjand Legal Medicine Center from 2011 to 2018

    by Ali Hosseininejad-Mohebati, Toba Kazemi, Marjan Farzad, Mostafa Jafarzadeh, Seyed Ali Moezi Bady, Nahid Azdaki, Saeede Khosravi Bizhaem

    Background: Coronary artery disease has recently increased from 20 to 45%. Previous studies emphasize a wide range of risk factors for coronary atherosclerosis. The role of inflammatory factors has been proven in the development of coronary artery atherosclerosis. Drugs are effective in coronary artery atherosclerosis by stimulating inflammatory factors. Objectives: This study evaluated the heart status regarding the history of drug and psychotropics use in corpses referred to Birjand Legal Medicine Center from 2011 to 2018. Materiald and Methods: In this case-control study, corpses referred to forensic medicine with a history of substance abuse (case group) and no history of substance abuse (control group) were selected. The data included pathological and toxicological autopsy results. Data analysis was performed using Mann-Whitney and chi-square tests and Spearman correlation coefficient. Results: Of 193 corpses, 126 were in the case group and 67 in the control group. The mean age was 41.82 ± 16.84. The Mann-Whitney test showed that heart weight was significantly higher in cases than in controls (P = 0.018). Mean heart dimensions in the case and control groups were 13 × 10 × 7 and 13 × 9 × 6, respectively, with a significant difference in one dimension (P = 0.014). Coronary artery stenosis results showed mean RC = 52.49, LC = 55.97, CX = 61.84, and LAD = 69.90. There was no significant positive correlation between drug abuse and atherosclerosis (r = 0.119, P = 0.09). Also, a higher prevalence of atherosclerosis was seen in males. Conclusions: Drug use can be a risk factor for cardiovascular diseases in people with substance abuse by changing the physical characteristics of the heart. Further studies must investigate the effect of drug use on coronary artery disease development and the factors intensifying these effects.

  • Open Access

    Infective Endocarditis: Clinical Characteristics and Echocardiographic Findings

    by Hoorak Poorzand, Fatemeh Hamidi, Fereshte Sheybani, Fereshteh Ghaderi, Afsoon Fazlinezhad, Hedieh Alimi, Leila Bigdelu, Saeede Khosravi Bizhaem

    Purpose: Infective endocarditis (IE) remains a disease with high morbidity and mortality. The aim of this study was to determine the clinical characteristics and echocardiographic features of patients with IE.Methods: We analyzed patients with either definitive or probable diagnosis of IE who were hospitalized in a teaching hospital in Mashhad, Iran between June 2011 and January 2020. Patients who survived were followed up by echocardiography for at least 6-month after hospital discharge.Results: A total of 82 cases with IE were included of which 62 (75.6%) received definitive diagnosis. The mean age was 39.7 ± 18.7 years and 52 (63.4%) were male. The most common preexisting structural cardiac abnormality that predispose patients to IE were congenital heart diseases (28 %) of which bicuspid aortic valve was more common (n = 12, 14.6%), followed by ventricular septal defect (n = 9, 11%) and Tetralogy of Fallot (TOF) (n = 2, 2.4%). Three (3.6 %) cases had rheumatic heart disease and 12 (14.6 %) were injecting drug users. The most common causative pathogen was Staphylococcus aureus, detected in 7 (19.4%) cases. Follow-up echocardiography revealed right or left ventricular failure in 10 (12.1%) cases. Cardiac complications occurred in 41 (50%) cases and systemic complications in 63 (76.8%). All-cause mortality was 41.5% (n = 34) and 6 (18.1%) patients died due to cardiovascular complications.Conclusions: The short- and long-term prognosis in IE was poor and the predictors for in-hospital and 1-year mortality were defined as heart failure and septic shock. Congenital heart disease and intravenous illicit drug using (IVDU) were the most common predisposing condition which may necessitate a revision in the IE prophylaxis recommendations.


  • Open Access

    Characteristics and outcomes of hospitalized patients with cardiovascular complications of COVID-19

    by Farzad Jalali, Farbod Hatami, Mehrdad Saravi, Iraj Jafaripour, Mohammad Taghi Hedayati, Kamyar Amin, Roghayeh Pourkia, Saeid Abroutan, Mostafa Javanian, Soheil Ebrahimpour, et al.

    Introduction: To address cardiovascular (CV) complications and their relationship to clinical outcomes in hospitalized patients with COVID-19. Methods: A total of 196 hospitalized patients with COVID-19 were enrolled in this retrospective single-center cohort study from September 10, 2020, to December 10, 2020, with a median age of 65 years (IQR, 52-77). Follow-up continued for 3 months after hospital discharge. Results: CV complication was observed in 54 (27.6%) patients, with arrhythmia being the most prevalent (14.8%) followed by myocarditis, acute coronary syndromes, ST-elevation myocardial infarction, cerebrovascular accident, and deep vein thrombosis in 15 (7.7%), 12 (6.1%), 10(5.1%), 8 (4.1%), and 4 (2%) patients, respectively. The proportion of patients with elevated high-sensitivity troponin I, N-terminal pro-B-type natriuretic peptide, left ventricular diastolic dysfunction, and heart failure with preserved ejection fraction was greater in the CV complication group. Severe forms of COVID-19 comprised nearly two-thirds (64.3%) of our study population and constituted a significantly higher share of the CV complication group members (75.9%vs 59.9%; P=0.036). Intensive care unit admission (64.8% vs 44.4%; P=0.011) and stay (5.5days vs 0 day; P=0.032) were notably higher in patients with CV complications. Among 196patients, 50 died during hospitalization and 10 died after discharge, yielding all-cause mortality of 30.8%. However, there were no between-group differences concerning mortality. Age, heart failure, cancer/autoimmune disease, disease severity, interferon beta-1a, and arrhythmia were the independent predictors of all-cause mortality during and after hospitalization. Conclusion: CV complications occurred widely among COVID-19 patients. Moreover,arrhythmia, as the most common complication, was associated with increased mortality.


  • Open Access

    Risk Factors Associated With the Extent of Coronary Vessel Involvement Across the Spectrum of Coronary Artery Disease

    by Ali Moezi, Maryam Soltani, Toba Kazemi, Saeede Khosravi Bizahem, Nasrin Amirabadizadeh, Nazanin Hanafi, Neda Partovi, Hamid Reza Mashreghimoghadam, Mohammad Yousef Ghoddusi, Majid Jafarnejad, et al.

    Background: Cardiovascular Disease (CVD) is one of the most important causes of mortality and morbidity in developed and developing countries. Objectives: This study aimed to evaluate the risk factors associated with the extent of coronary vessel involvement across the spectrum of Coronary Artery Disease (CAD) in patients referring to the Cardiac Ward of Vali-Asr Hospital of Birjand, Iran. Methods: A cross-sectional study was conducted on 3,394 patients undergoing coronary angiography at the Cardiac Ward of Vali-Asr Hospital of Birjand, Iran, in 2011-2015. Subjects were assigned to four groups in terms of the extent of coronary vessel involvement: Normal CAD, non-significant CAD, CAD, and non-obstructive CAD. Adjusted odds ratios and 95% confident intervals were calculated by including all variables with P values < 0.05 into the multivariate model to control for confounding factors. Data were analyzed using SPSS version 22. Results: Among male and female patients, those aged 45-65 years needed angiography more than other groups. Multiple logistic regression analysis showed that diabetes, male gender, FBS, and history of hypertension significantly increased the likelihood of coronary vessel involvement (P ≤ 0.05). Conclusions: The findings of the present study imply that age, male gender, FBS, and history of hypertension are the independent risk factors for the extent of coronary vessel involvement in CAD and non-significant CAD groups. To reduce the rates and consequences of CAD, it is paramount to control cardiovascular risk factors, screen susceptible populations at risk, and improve coronary interventional services.